Advertisement
Canada markets open in 1 hour 34 minutes
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    84.06
    +0.49 (+0.59%)
     
  • Bitcoin CAD

    87,668.53
    +421.90 (+0.48%)
     
  • CMC Crypto 200

    1,385.18
    -11.35 (-0.81%)
     
  • GOLD FUTURES

    2,357.20
    +14.70 (+0.63%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,748.75
    +181.25 (+1.03%)
     
  • VOLATILITY

    15.65
    +0.28 (+1.82%)
     
  • FTSE

    8,113.75
    +34.89 (+0.43%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6829
    +0.0008 (+0.12%)
     

Company News for Jan 11, 2023

  • Shares of TD SYNNEX Corp. SNX surged 4.7% after reporting fourth quarter fiscal 2022 adjusted earnings per share of $3.44, surpassing the Zacks Consensus Estimate of $2.92.

  • Shares of Albertsons Companies Inc. ACI gained 1.8% after posting third quarter fiscal 2022 adjusted earnings per share of $0.87, outpacing the Zacks Consensus Estimate of $0.67.

  • Microsoft Corp.’s MSFT shares rose 0.8% following news that the company is mulling investing $10 billion in ChatGPT-owner OpenAI.

  • CureVac N.V.’s CVAC shares soared 20.6% after the company announced its plan to advance patient trials of its mRNA vaccines for COVID-19 and the flu.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Microsoft Corporation (MSFT) : Free Stock Analysis Report

Albertsons Companies, Inc. (ACI) : Free Stock Analysis Report

TD SYNNEX Corp. (SNX) : Free Stock Analysis Report

CureVac N.V. (CVAC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research